TRADING UPDATES: Genflow patent progress; Accsys new debt facilities
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 2.05p on 11-11-2025 at 14:50:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 2.20p |
| Sell | 1.90p |
| Last Trade: | Buy 240.00 at 2.07p |
| Day's Volume: | 388,767 |
| Last Close: | 2.05p |
| Open: | 1.94p |
| ISIN: | GB00BP2C3V08 |
| Day's Range | 1.94p - 2.05p |
| 52wk Range: | 0.575p - 2.60p |
| Market Capitalisation: | £10.12m |
| VWAP: | 1.950201p |
| Shares in Issue: | 493.55m |
Sector: Medicine and Biotech
Genflow Biosci (GENF) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 240 | 2.07p | Ordinary |
14:26:04 - 11-Nov-25 |
| Buy* | 141 | 2.07p | Ordinary |
14:25:07 - 11-Nov-25 |
| Buy* | 2,403 | 2.07p | Ordinary |
11:21:25 - 11-Nov-25 |
| Buy* | 1,442 | 2.07p | Ordinary |
11:21:24 - 11-Nov-25 |
| Sell* | 90,000 | 1.9422p | Ordinary |
11:07:26 - 11-Nov-25 |
| Sell* | 13,217 | 1.9633p | Ordinary |
09:36:30 - 11-Nov-25 |
| Sell* | 48 | 1.90p | Ordinary |
08:30:29 - 11-Nov-25 |
| Sell* | 125,000 | 1.9633p | Ordinary |
08:14:05 - 11-Nov-25 |
| Sell* | 5 | 1.90p | Ordinary |
16:07:19 - 10-Nov-25 |
| Sell* | 116,608 | 1.96222p | Ordinary |
16:06:49 - 10-Nov-25 |
Genflow Biosci (GENF) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Oct 2025 7:00 am | RNS | Total Voting Rights |
| 24th Oct 2025 7:00 am | RNS | Holding(s) in Company |
| 22nd Oct 2025 7:00 am | RNS | Second European Patent Application |
| 20th Oct 2025 7:00 am | RNS | Recognition of Patentability of Claims |
| 10th Oct 2025 7:00 am | RNS | Update on Animal Health Program |
| 9th Oct 2025 7:00 am | RNS | Update, Equity Issue and PDMR Notification |
| 2nd Oct 2025 12:37 pm | RNS | Issue of Equity - Correction |
| 2nd Oct 2025 7:59 am | RNS | Issue of Equity |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |
| 19th Sep 2025 12:40 pm | RNS | Holding(s) in Company |